TOP STORIES

• BUSINESS Novartis’s Third-Party Probe Finds “No Evidence” Indicating Data Falsification by Ex-Employee; Truth behind Diovan Woe Not Yet Uncovered
  July 30, 2013

• REGULATORY PAFSC’s Second Committee Recommends Approval for Bronchial Asthma Treatment Flutiform, Others
  July 29, 2013

• ORGANIZATION Red Cross Hospitals to Share Information on Drug Discount Rates
  July 29, 2013

• REGULATORY MHLW-MEXT Joint Committee Agrees to Require Researchers to Store Clinical Research Data for Long Periods
  July 26, 2013

• BUSINESS OncoTherapy, Panasonic Healthcare to Codevelop Immune Monitoring System to Evaluate Effects of Cancer Vaccines
  July 26, 2013

• REGULATORY MHLW Might Submit Bill on Online OTC Sales to Extraordinary Diet Session: PFSB Head
  July 25, 2013

• BUSINESS Otsuka to Develop Sensor-Embedded Abilify to Improve Drug Compliance
  July 24, 2013

• REGULATORY Pilot Program for Japan-Version “Compassionate Use” System to Begin at National Cancer Center
  July 23, 2013

• REGULATORY 1st Committee to Discuss Approval of New Products Including Janssen’s Extended Release Schizophrenia Treatment
  July 23, 2013

• REGULATORY MHLW Mulls “Ultra-Orphan” Drug System; Designation Might Become Possible with Pre-Clinical, Healthy Subject Data
  July 22, 2013

• REGULATORY US Aims for Lifting of Ban on Mixed Care: Prof. Murakami of Yamagata University
  July 22, 2013

• ORGANIZATION FPMAJ Settles on Industry View for TPP, Demands Intellectual Property Protection on Par with Japanese Rules
  July 19, 2013

• REGULATORY South Korean MOHW Officials Announce Roadmap for South Korea to Become No. 7 Worldwide in New Drug Development by 2020
  July 19, 2013

• BUSINESS Pfizer Paid 23.9 Billion Yen to Physicians, Medical Institutions in FY2012; 1st Disclosure under JPMA Guidelines
  July 18, 2013

• ACADEMIA University’s Seriousness to Unravel Diovan Saga Called into Question
  July 17, 2013

• REGULATORY 2nd Committee on Drugs to Discuss Approval for Asthma Treatment Flutiform on July 26
  July 17, 2013

• REGULATORY MHLW, US FDA to Exchange Information with a View to Standardizing Review Guidelines for Regenerative Medicines
  July 17, 2013

• REGULATORY Health Ministry to Set Up Committee on Diovan Studies, Compile Preventive Measures for Clinical Data Manipulation
  July 16, 2013

• REGULATORY MHLW Presses Kyoto Prefectural University of Medicine to Carry on Diovan Probe
  July 16, 2013

• ACADEMIA “Data Manipulated” in KYOTO Heart Study: Univ. Probe
  July 12, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 213
• 214
• 215
• 216
• 217
• 218
• 219
• 220
• 221
• …
• Next ›
• 最終 »